MedPath

Effect of exposure of mosquito repellent liquid vaporizer among inmates of households.

Phase 4
Completed
Registration Number
CTRI/2021/11/037745
Lead Sponsor
Ms Sumitomo Chemical India Pvt Ltd
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
113
Inclusion Criteria

1.Written informed consent from the subject.

2.Age more than 12 years completed.

Exclusion Criteria

1.Subjects with any condition which in the opinion of the investigator makes the subject unsuitable for inclusion.

2.Pregnancy

3.Lactation

4.Chronic respiratory disorder

5.Simultaneous participation in any other trial

Study & Design

Study Type
PMS
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Change from baseline in vital signs. <br/ ><br>2. Change from baseline in clinical chemistry, urine analysis and haematology. <br/ ><br>3. Adverse events reporting for 365 days after starting the use of vaporizer.Timepoint: 90, 180 and 365 days.
Secondary Outcome Measures
NameTimeMethod
ot applicableTimepoint: Not applicable
© Copyright 2025. All Rights Reserved by MedPath